A second coronavirus vaccine could get FDA authorization in a matter of days.
On Thursday, an FDA panel endorsed Moderna’s vaccine, clearing the way for emergency authorization, potentially as soon as Friday.
Moderna’s vaccine was more than 90% effective in late-stage clinical trials and does not require ultra-cold storage like the Pfizer vaccine. If approved, up to 6 million doses could be distributed within the U.S. next week.
JUST IN: A panel of advisers recommended that Moderna's COVID-19 vaccine be authorized for emergency use in the U.S. The FDA is expected to make a decision quickly.https://t.co/gB7o5xgGJc
— NPR (@NPR) December 17, 2020
Are you starting to feel encouraged about the possibility of the pandemic ending? When do you think things will fully return to ‘normal’?